RFA Treatment for Papillary Thyroid Microcarcinoma
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT05189821
- Status
- Recruiting
Conditions
- Papillary Thyroid Microcarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Radiofrequency Ablation — PROCEDUREUltrasound guided radiofrequency ablation
Study Details
Thyroid surgery has always been the mainstay of treatment for thyroid cancer. Thyroid surgery carries a low risk of complications that include recurrent or superior laryngeal nerve injury leading to voice changes, hypoparathyroidism, hypothyroidism with need for thyroid hormone supplementation, and unsightly scarring. Although many patients with thyroid cancer find these risks acceptable, these risks are sometimes less acceptable to patients with benign disease. In an era when the medical field is treating thyroid diseases less aggressively, there is a pressing need to identify approaches to treat indolent malignant disease less invasively. The purpose of this observational study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of Papillary Thyroid Microcarcinoma (PTMC) in patients that have already agreed to RFA procedure based on treating physician recommendation. This is a data collection study in which we ask participants to give us access to information generated before and after RFA treatment of their condition. The RFA procedure uses image guidance to place an electrode through the skin into the target tumor. In RFA, high-frequency electrical currents are passed through an electrode, creating a small region of heat to treat the lesion.
Key Dates
- Start date
- Nov 1, 2021
- Status verified
- May 2026
- Primary completion
- Nov 30, 2027
- Completion
- Nov 30, 2028
Study Design
- Enrollment
- 50 participants (estimated)
Primary Outcome Measure
Complete sonographic disappearance (CD) [ Time Frame: 12 months ]
Central Contacts
- Jennifer H Kuo, MD MS212-305-6969
- Vilma Rosario
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University | New York | New York | 10032 |
Find similar trials in New York, NY
Related Studies
- Active Surveillance of Papillary Thyroid MicrocarcinomaRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Decision Aid Efficacy in Low Risk Thyroid CancerNot Yet Recruiting · University of Maryland, Baltimore · Baltimore, Maryland